PCV57 COST-EFFECTIVENESS OF NEBIVOLOL VERSUS ATENOLOL AND ACE INHIBITOR MONOTHERAPY IN PATIENTS WITH MODERATE HYPERTENSION
Abstract
Authors
B Lippert B Brüggenjürgen SN Willich
B Lippert B Brüggenjürgen SN Willich
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now